New precision therapies reshape the future of pancreatitis treatment

Pancreatitis remains a major global health burden, encompassing acute pancreatitis (AP), chronic pancreatitis (CP), and autoimmune pancreatitis (AIP). AP affects 13-49 people per 100,000 annually, with up to 20% developing severe…

Continue Reading